By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Collegium Pharmaceutical, Inc. 

400 Highland Corporate Drive

Cumberland  Rhode Island  02864  U.S.A.
Phone: 401-762-2000 Fax: 401-762-2043



Company News
BioDelivery (BDSI) And Collegium (COLL) Announce The Signing Of A Licensing Agreement For ONSOLIS In The U.S. 5/12/2016 6:46:39 AM
Collegium (COLL) Announces FDA Acceptance Of IND Application For Abuse-Deterrent, Hydrocodone Deterx 1/21/2016 7:41:36 AM
Collegium (COLL) Delays Launch of OxyContin Variation Xtampza 12/30/2015 6:30:34 AM
Collegium (COLL) Announces Publication Of Nasal Human Abuse Potential Study In American Academy Of Pain Medicine 12/16/2015 8:05:10 AM
Collegium (COLL) To Present At The 27th Annual Piper Jaffray Healthcare Conference 11/30/2015 8:27:38 AM
Collegium (COLL) Reports Third Quarter Financial Results And Provides Corporate Update 11/12/2015 7:23:17 AM
Collegium (COLL) To Host Conference Call To Discuss Q3 Financial Results And Provide Corporate Update 11/9/2015 8:36:50 AM
Collegium (COLL) Announces FDA Tentative Approval For Xtampza(TM) ER, A Novel Abuse-Deterrent Analgesic For Chronic Pain 11/9/2015 7:42:17 AM
Collegium (COLL) Falls in Aftermarket Trading After FDA Delays Ruling on Opiod Painkiller 10/12/2015 3:31:12 PM
FDA Panel Gives Green Light to Collegium (COLL)'s Painkiller Xtampza ER 9/14/2015 9:38:18 AM